F2rtm2.1Jogr
Targeted Allele Detail
|
|
| Symbol: |
F2rtm2.1Jogr |
| Name: |
coagulation factor II thrombin receptor; targeted mutation 2.1, John H Griffin |
| MGI ID: |
MGI:6781957 |
| Synonyms: |
QQ46-PAR1 |
| Gene: |
F2r Location: Chr13:95738311-95754995 bp, - strand Genetic Position: Chr13, 50.21 cM
|
| Alliance: |
F2rtm2.1Jogr page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:261560
|
| Parent Cell Line: |
C2 (Nagy) (ES Cell)
|
| Strain of Origin: |
C57BL/6NTac
|
|
| Allele Type: |
|
Targeted (Not Applicable) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: A mutation was engineered in exon 2 to change arginine codon 46 (AGG) to a glutamine codon (CAG)(p.R46Q) and an FRT site flanked neomycin resistance gene cassette was inserted into intron 1. The neo cassette was removed through subsequent flp-mediated recombination. The mutation prevents cleavage at that residue by activated protein C (APC).
(J:261560)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any F2r Mutation: |
23 strains or lines available
|
|
| Original: |
J:261560 Sinha RK, et al., PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. Blood. 2018 Mar 15;131(11):1163-1171 |
| All: |
5 reference(s) |
|